Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The review found that basal cell carcinomas on the scalp are not more aggressive than those in other locations.

Rhabdomyosarcoma is the most common head and neck cancer in children, requiring complex treatment.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Dr. Zitelli emphasized that "Mohs surgery" should only be called that when one doctor does both the surgery and pathology.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a viable alternative.

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Cancer patients in sub-Saharan Africa face significant challenges during chemotherapy, highlighting the need for better patient care and support.

Hair loss from chemotherapy causes significant distress and affects social roles for ovarian and uterine cancer patients.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Chemotherapy often causes hair loss, so patients should be counseled to reduce anxiety.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.